New Options for Avoiding a Dedicated TQT Study — The

Toronto, ON (PRWEB) September 12, 2022 -- In this webinar, the featured speakers will be discussing the impact of the new ICH E14 and S7B revisions and how

Related Keywords

United Kingdom , Borje Darpo , Duncan Cantor , Robert Kleiman , Linkedin , Honeycomb Worldwide Inc , Twitter , Corporate Communications , Vice President , Chief Medical Officer , Chief Scientific Advisor , Cardiac Safety , New Options , Trial Anywhere , Media Contact , Life Science , Press Release ,